Profile data is unavailable for this security.
About the company
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.
- Revenue in USD (TTM)30.07m
- Net income in USD-24.91m
- Incorporated1990
- Employees139.00
- LocationStereotaxis Inc710 N Tucker Blvd, Ste 110ST. LOUIS 63101United StatesUSA
- Phone+1 (314) 678-6100
- Fax+1 (314) 678-6159
- Websitehttps://www.stereotaxis.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nano-X Imaging Ltd | 12.30m | -55.71m | 164.03m | 165.00 | -- | 0.9888 | -- | 13.33 | -0.8839 | -0.8839 | 0.195 | 2.40 | 0.0683 | 13.17 | 7.18 | 74,557.58 | -30.95 | -28.17 | -33.30 | -31.20 | -98.04 | -- | -452.82 | -1,072.25 | 3.93 | -- | 0.0201 | -- | 13.91 | -- | 11.95 | -- | 85.79 | -- |
| Inogen Inc | 348.67m | -22.75m | 165.61m | 766.00 | -- | 0.8615 | -- | 0.475 | -0.8571 | -0.8571 | 13.11 | 7.08 | 1.17 | 7.66 | 10.19 | -- | -7.65 | -13.24 | -10.01 | -16.09 | 44.24 | 44.13 | -6.52 | -14.48 | 2.71 | -- | -- | -- | 3.86 | 2.48 | 36.62 | -- | -10.01 | -- |
| Acme United Corp | 194.96m | 10.02m | 171.34m | 633.00 | 18.49 | 1.48 | 10.55 | 0.8789 | 2.43 | 2.43 | 47.35 | 30.41 | 1.15 | 2.03 | 6.35 | 307,993.70 | 5.92 | 7.26 | 6.81 | 8.54 | 39.51 | 36.34 | 5.14 | 5.68 | 1.75 | 8.57 | 0.1962 | 18.40 | 1.56 | 6.42 | -43.67 | 12.70 | 33.59 | 4.56 |
| InfuSystem Holdings Inc | 143.44m | 6.63m | 177.24m | 502.00 | 27.82 | 3.09 | 8.88 | 1.24 | 0.3153 | 0.3153 | 6.81 | 2.84 | 1.41 | 10.59 | 6.51 | -- | 6.49 | 2.25 | 7.97 | 2.69 | 55.98 | 54.61 | 4.62 | 1.83 | 1.53 | 9.37 | 0.255 | -- | 6.36 | 8.05 | 182.60 | -17.49 | -12.48 | -- |
| Citrine Global Corp | 0.00 | -1.74m | 184.51m | 18.00 | -- | -- | -- | -- | -0.0016 | -0.0016 | 0.00 | -0.0031 | 0.00 | -- | -- | 0.00 | -118.80 | -238.43 | -- | -- | -- | -- | -- | -186,483.40 | -- | -2.10 | -- | -- | -- | -- | 25.99 | -- | -- | -- |
| Accendra Health Inc | 6.71bn | -410.53m | 184.98m | 13.50k | -- | -- | -- | 0.0276 | -5.33 | -17.41 | 86.97 | -5.56 | 1.47 | 7.59 | 15.52 | 496,837.20 | -9.01 | -0.3346 | -17.40 | -0.5248 | 26.13 | 18.20 | -6.12 | -0.146 | 0.8386 | 1.67 | 1.25 | -- | 3.55 | 3.04 | -778.15 | -- | 34.30 | -- |
| Lucid Diagnostics Inc | 4.40m | -65.84m | 188.53m | 72.00 | -- | -- | -- | 42.86 | -0.8968 | -0.8968 | 0.0526 | 0.1973 | 0.1161 | 12.24 | 14.94 | 61,097.22 | -140.60 | -139.37 | -301.55 | -297.39 | -58.13 | -- | -1,211.30 | -2,492.79 | 1.88 | -- | 0.4633 | -- | 79.00 | -- | -0.6817 | -- | -- | -- |
| Rapid Micro Biosystems Inc | 30.52m | -44.29m | 191.92m | 163.00 | -- | 4.33 | -- | 6.29 | -0.9984 | -0.9984 | 0.6884 | 1.00 | 0.3209 | 1.33 | 6.40 | 187,257.70 | -46.56 | -38.13 | -56.14 | -43.36 | 7.72 | -27.98 | -145.11 | -253.02 | 2.95 | -- | 0.3003 | -- | 24.57 | 11.18 | 10.63 | -- | -4.24 | -- |
| Electromed Inc | 68.86m | 8.99m | 196.12m | 177.00 | 23.07 | 4.32 | 19.25 | 2.85 | 1.03 | 1.03 | 7.86 | 5.49 | 1.28 | 4.59 | 2.69 | 389,045.20 | 16.78 | 9.33 | 20.17 | 11.04 | 78.23 | 76.56 | 13.06 | 8.40 | 4.49 | -- | 0.00 | 0.00 | 16.97 | 14.53 | 46.35 | 12.62 | -20.72 | -- |
| Stereotaxis Inc | 30.07m | -24.91m | 201.58m | 139.00 | -- | 31.40 | -- | 6.70 | -0.281 | -0.281 | 0.3393 | 0.1266 | 0.6232 | 1.47 | 4.54 | 216,359.70 | -48.96 | -31.30 | -85.25 | -43.31 | 53.07 | 62.81 | -78.56 | -56.04 | 0.8108 | -- | 0.00 | -- | 0.5491 | -1.41 | -14.95 | -- | 2.89 | -- |
| Anika Therapeutics Inc | 82.20m | 13.91m | 207.09m | 288.00 | 15.25 | 1.41 | 10.24 | 2.52 | 0.9419 | -2.28 | 5.70 | 10.18 | 0.3907 | 0.486 | 3.25 | 285,430.60 | 6.61 | -1.87 | 7.39 | -2.06 | 54.29 | 60.74 | 16.92 | -4.73 | 4.47 | -- | 0.00 | -- | -0.7327 | 0.9077 | -156.70 | -- | 24.14 | -- |
| SANUWAVE Health Inc | 41.28m | -7.04m | 208.62m | 46.00 | -- | -- | -- | 5.05 | -0.9346 | -0.9346 | 4.68 | -0.3418 | 1.44 | 1.75 | 11.07 | 897,456.50 | -24.53 | -124.81 | -- | -- | 78.26 | 71.67 | -17.06 | -144.71 | 0.808 | 0.0999 | 1.14 | -- | 59.99 | 99.65 | -21.56 | -- | 55.47 | -- |
| Utah Medical Products Inc | 38.63m | 11.62m | 212.23m | 155.00 | 18.84 | 1.80 | 14.59 | 5.49 | 3.54 | 3.54 | 11.75 | 36.91 | 0.307 | 1.92 | 10.38 | 249,245.20 | 9.24 | 12.08 | 9.48 | 12.53 | 57.10 | 60.88 | 30.08 | 31.04 | 29.36 | -- | 0.00 | 37.43 | -18.56 | -2.70 | -16.60 | -0.8254 | -59.49 | 1.83 |
| CVRx Inc | 56.65m | -53.31m | 214.70m | 223.00 | -- | 5.46 | -- | 3.79 | -2.04 | -2.04 | 2.17 | 1.49 | 0.4756 | 0.6837 | 5.68 | 254,040.40 | -44.76 | -39.12 | -49.79 | -42.10 | 85.33 | 82.74 | -94.10 | -130.77 | 6.72 | -8.80 | 0.5574 | -- | 10.45 | 56.40 | 11.10 | -- | 13.27 | -- |
| KORU Medical Systems Inc | 39.07m | -3.71m | 220.96m | 80.00 | -- | 13.41 | -- | 5.66 | -0.0807 | -0.0807 | 0.8482 | 0.3557 | 1.43 | 3.53 | 7.39 | 488,383.00 | -13.62 | -19.85 | -18.41 | -23.16 | 62.32 | 59.62 | -9.50 | -24.86 | 1.92 | -- | 0.0335 | -- | 17.98 | 7.75 | 55.85 | -- | 25.82 | -- |
| OraSure Technologies Inc | 125.70m | -60.24m | 225.96m | 501.00 | -- | 0.6289 | -- | 1.80 | -0.8107 | -0.8107 | 1.69 | 5.01 | 0.2834 | 2.07 | 4.91 | 250,904.20 | -13.08 | -0.8506 | -14.16 | -0.9596 | 40.41 | 44.80 | -46.15 | -1.39 | 6.20 | -- | 0.0005 | -- | -54.17 | 3.75 | -136.34 | -- | -16.43 | -- |
Data as of Mar 02 2026. Currency figures normalised to Stereotaxis Inc's reporting currency: US Dollar USD
37.12%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| DAFNA Capital Management LLCas of 02 Jan 2026 | 13.68m | 14.66% |
| Lagoda Investment Management LPas of 31 Dec 2025 | 4.86m | 5.21% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 3.73m | 3.99% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 3.13m | 3.35% |
| Arbiter Partners Capital Management LLCas of 31 Dec 2025 | 2.88m | 3.09% |
| Geode Capital Management LLCas of 31 Dec 2025 | 1.57m | 1.68% |
| Essex Investment Management Co. LLCas of 31 Dec 2025 | 1.56m | 1.67% |
| Archon Capital Management LLCas of 31 Dec 2025 | 1.23m | 1.31% |
| Warberg Asset Management LLCas of 31 Dec 2025 | 1.11m | 1.19% |
| Prescott Group Capital Management LLCas of 31 Dec 2025 | 901.25k | 0.97% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
